Solange A. Valdes

516 citations

18 papers · 440 indexed · h-index 11

Co-authors: Zhengrong CuiXu LiSachin G. Thakkar Abdulaziz M. Aldayel Stephen D. Hursting Hannah L. O’Mary Youssef W. Naguib Stephanie Hufnagel
Topics: RNA Interference and Gene Delivery (7 papers)Immunotherapy and Immune Responses (6 papers)Immune cells in cancer (5 papers)
Cited by: Pharmaceutical Science Biomaterials Immunology
Journals: SHILAP Revista de lepidopterologíaACS Applied Materials & Interfaces Journal of Controlled Release
Partner nations: United States China Saudi Arabia

In The Last Decade

Solange A. Valdes

17 papers receiving 435 citations

Peers

Countries citing papers authored by Solange A. Valdes

Since Specialization

Citations

This map shows the geographic impact of Solange A. Valdes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Solange A. Valdes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Solange A. Valdes more than expected).

Fields of papers citing papers by Solange A. Valdes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Solange A. Valdes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Solange A. Valdes. The network helps show where Solange A. Valdes may publish in the future.

Co-authorship network of co-authors of Solange A. Valdes

This figure shows the co-authorship network connecting the top 25 collaborators of Solange A. Valdes. A scholar is included among the top collaborators of Solange A. Valdes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Solange A. Valdes. Solange A. Valdes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Effect of nanoparticle size on their distribution and retention in chronic inflammation sites 2023 ·SHILAP Revista de lepidopterología ·Abdulaziz M. Aldayel,Stephanie Hufnagel,Hannah L. O’Mary,Solange A. Valdes,(unknown),Haiyue Xu,Zhengrong Cui	10
2	4-(N)-Docosahexaenoyl 2’, 2’-difluorodeoxycytidine induces immunogenic cell death in colon and pancreatic carcinoma models as a single agent 2021 ·Cancer Chemotherapy and Pharmacology ·Stephanie Hufnagel,Haiyue Xu,(unknown),Solange A. Valdes,(unknown),Stephen D. Hursting,Zhengrong Cui	3
3	Effect of surface mannosylation on the cytotoxicity and cellular uptake of stearoyl gemcitabine-incorporated, acid-sensitive micelles 2021 ·Colloids and Interface Science Communications ·(unknown),Haiyue Xu,Solange A. Valdes,Youssef W. Naguib,Zhengrong Cui	1
4	Effect of a Solid Lipid Nanoparticle Formulation on the Bioavailability of 4-(N)-Docosahexaenoyl 2′, 2′-Difluorodeoxycytidine After Oral Administration 2020 ·AAPS PharmSciTech ·Solange A. Valdes,(unknown),Dharmika S.P. Lansakara-P,Zhengrong Cui	8
5	Tumor-Associated Macrophage-Mediated Targeted Therapy of Triple-Negative Breast Cancer 2020 ·UNC Libraries ·Youssef W. Naguib,Zhengrong Cui,Mengmeng Niu,Stephen D. Hursting,Solange A. Valdes	0
6	Intranasal delivery of a nicotine vaccine candidate induces antibodies in mouse blood and lung mucosal secretions that specifically neutralize nicotine 2020 ·Drug Development and Industrial Pharmacy ·(unknown),Haiyue Xu,Solange A. Valdes,Zhengrong Cui	9
7	Zoledronic Acid-containing Nanoparticles With Minimum Premature Release Show Enhanced Activity Against Extraskeletal Tumor 2019 ·ACS Applied Materials & Interfaces ·Xu Li,Solange A. Valdes,(unknown),Stephanie Hufnagel,Stephen D. Hursting,Zhengrong Cui	38
8	Effect of the Ratio of Betamethasone to TNF-α siRNA Coencapsulated in Solid Lipid Nanoparticles on the Acute Proinflammatory Activity of the Nanoparticles 2019 ·Molecular Pharmaceutics ·Hannah L. O’Mary,Mahmoud S. Hanafy,Abdulaziz M. Aldayel,Solange A. Valdes,(unknown),Stephanie Hufnagel,John J. Koleng,Zhengrong Cui	15
9	A solid lipid nanoparticle formulation of 4-(N)-docosahexaenoyl 2′, 2′-difluorodeoxycytidine with increased solubility, stability, and antitumor activity 2019 ·International Journal of Pharmaceutics ·Solange A. Valdes,(unknown),(unknown),Dharmika S.P. Lansakara-P,Sachin G. Thakkar,Zhengrong Cui	25
10	Intranasal immunization with aluminum salt-adjuvanted dry powder vaccine 2018 ·Journal of Controlled Release ·Sachin G. Thakkar,Zachary N. Warnken,(unknown),Solange A. Valdes,Abdulaziz M. Aldayel,Haiyue Xu,Robert O. Williams,Zhengrong Cui	45
11	Lipid nanoparticles with minimum burst release of TNF-α siRNA show strong activity against rheumatoid arthritis unresponsive to methotrexate 2018 ·Journal of Controlled Release ·Abdulaziz M. Aldayel,Hannah L. O’Mary,Solange A. Valdes,Xu Li,Sachin G. Thakkar,(unknown),Zhengrong Cui	106
12	Acid-Sensitive Sheddable PEGylated, Mannose-Modified Nanoparticles Increase the Delivery of Betamethasone to Chronic Inflammation Sites in a Mouse Model 2017 ·Molecular Pharmaceutics ·Hannah L. O’Mary,Abdulaziz M. Aldayel,Solange A. Valdes,Youssef W. Naguib,Xu Li,(unknown),Zhengrong Cui	15
13	Aluminum (Oxy)Hydroxide Nanosticks Synthesized in Bicontinuous Reverse Microemulsion Have Potent Vaccine Adjuvant Activity 2017 ·ACS Applied Materials & Interfaces ·Xu Li,Stephanie Hufnagel,Haiyue Xu,Solange A. Valdes,Sachin G. Thakkar,Zhengrong Cui,Hugo Celio	47
14	Preclinical Evaluation of the Short-Term Toxicity of 4-(N)-Docosahexaenoyl 2´, 2´- Difluorodeoxycytidine (DHA-dFdC) 2017 ·Pharmaceutical Research ·Solange A. Valdes,Youssef W. Naguib,Rick A. Finch,Wallace B. Baze,Christopher A. Jolly,Zhengrong Cui	5
15	Reverse Microemulsion-Based Synthesis of (Bis)phosphonate–Metal Materials with Controllable Physical Properties: An Example Using Zoledronic Acid–Calcium Complexes 2017 ·ACS Applied Materials & Interfaces ·Xu Li,Youssef W. Naguib,Solange A. Valdes,Stephanie Hufnagel,Zhengrong Cui	16
16	Oral 4-(N)-stearoyl gemcitabine nanoparticles inhibit tumor growth in mouse models 2017 ·Oncotarget ·Caixia Wang,(unknown),Michael A. Sandoval,Solange A. Valdes,Zhe Chen,Dharmika S.P. Lansakara-P,Maolin Du,Yanchun Shi,Zhengrong Cui	16
17	Synthesis, Characterization, and In Vitro and In Vivo Evaluations of 4-(N)-Docosahexaenoyl 2′, 2′-Difluorodeoxycytidine with Potent and Broad-Spectrum Antitumor Activity 2016 ·Neoplasia ·Youssef W. Naguib,Dharmika S.P. Lansakara-P,Laura M. Lashinger,B. Leticia Rodriguez,Solange A. Valdes,Mengmeng Niu,Abdulaziz M. Aldayel,Lan Peng,Stephen D. Hursting,Zhengrong Cui	17
18	Tumor-Associated Macrophage-Mediated Targeted Therapy of Triple-Negative Breast Cancer 2016 ·Molecular Pharmaceutics ·Mengmeng Niu,Solange A. Valdes,Youssef W. Naguib,Stephen D. Hursting,Zhengrong Cui	64

About Solange A. Valdes

Solange A. Valdes is a scholar working on Immunology, Pharmaceutical Science and Biomaterials, having authored 18 papers that have together received 440 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (7 papers), Immunotherapy and Immune Responses (6 papers) and Immune cells in cancer (5 papers). The work is most often cited by research in Pharmaceutical Science (72 citations), Biomaterials (85 citations) and Immunology (137 citations). Solange A. Valdes has collaborated with scholars based in United States, China and Saudi Arabia. Frequent co-authors include Zhengrong Cui, Xu Li, Sachin G. Thakkar, Abdulaziz M. Aldayel, Stephen D. Hursting, Hannah L. O’Mary, Youssef W. Naguib, Stephanie Hufnagel, Haiyue Xu and Mengmeng Niu. Their work appears in journals such as SHILAP Revista de lepidopterología, ACS Applied Materials & Interfaces and Journal of Controlled Release.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact